
Switzerland · Medical devices startup
CeQur is a medical device company based in Horw, Switzerland, with a US operational headquarters in Greenville, South Carolina.
Funding reportedLast round: Series C
CeQur is a medical device company based in Horw, Switzerland, with a US operational headquarters in Greenville, South Carolina.
Founded in 2008 as a spin-out from Danfoss A/S, CeQur focuses on simplifying mealtime insulin delivery for individuals with type 1 and type 2 diabetes who need multiple daily injections. The company is dedicated to making insulin regimens easier to follow, helping users maintain better blood glucose control. The primary product offered by CeQur is the CeQur SimplicityTM, a wearable, injection-free insulin patch designed for bolus dosing. This single-use device delivers rapid-acting insulin through a flexible cannula and can hold up to 200 units, replacing approximately 12 daily injections over four days. CeQur also provides regulatory and commercialization services, along with support and training for patients and healthcare professionals. The company targets adults with diabetes who are looking for a discreet and convenient alternative to traditional insulin delivery methods.
Funding, as reported
From CeQur's own website: 6 on the team.
What they build
Known for
health careconsumersdrug deliverymedical equipment manufacturinginformation technology & servicessingle-userapid-actinghospital & health carediscreetmealtimemedicaldiscreet dosinginsulin dosinginsulinb2cinsulin patch
Built with from their website
Microsoft ExchangeSalesforceMicrosoft 365 Apps & ServicesGoDaddy DomainsAmazon AWSMicrosoft Exchange OnlineMicrosoft 365OutlookMicrosoft Email ProvidersGoDaddy Hosting
Salesforce Sales CloudGoogle Search Console
Add your raise, your deck and your story, and put CeQur in front of investors. Or tell us what we have wrong.